|
|
|
|
|
|
Free Newsletters
Archive
My eNewsletters
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Login
Become a Member
Discussion Forums
FAQ
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Career Definitions
Labor Market Reports
Education & Training
Regions
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
NC-Based Arbovax Receives $150K Loan from Biotech Center
8/18/2008
August 14, 2008 – Arbovax, Inc. has received a small business research loan of $150,000 from the North Carolina Biotechnology Center to support the company’s research and development program. “We are delighted to receive this level of support from the Biotechnology Center,” said Malcolm Thomas, CEO. “It will greatly assist us in acquiring some essential equipment as well as support our research efforts.
These programs from NCBC are of great value to early-stage companies such as ours, allowing us to stretch our funding dollars and giving us the additional time that is so critical to meeting milestones and raising the next round of financing.” Arbovax is developing a novel and innovative technology to use in producing vaccines against insect-borne viruses.
The World Health Organization ranks Arbovax’s initial focus, dengue fever, second only to malaria in its devastating global impact. The company’s core technology, developed by Drs. Dennis Brown and Raquel Hernandez of North Carolina State University, provides a platform that offers improved vaccine technology in a cost-effective manner targeting a portfolio of arthropod-borne diseases including dengue fever, Japanese encephalitis, West Nile virus, chikungunya fever and yellow fever. The Biotechnology Center is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business and education statewide. Contact Information: Malcolm Thomas President and CEO Arbovax, Inc. (919) 655 0412 x2222 mthomas@arbovax.com www.arbovax.com Jim Shamp News & Publications Editor North Carolina Biotechnology Center (919) 541-9366 Jim_shamp@ncbiotech.org www.ncbiotech.org
|
|
|
|
|
|
|
|
|
|
|
|